Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Non-cash Items (2017 - 2025)

Historic Non-cash Items for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $3.1 million.

  • Puma Biotechnology's Non-cash Items fell 1916.49% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 1916.49%. This contributed to the annual value of $3.6 million for FY2024, which is 22772.07% up from last year.
  • As of Q3 2025, Puma Biotechnology's Non-cash Items stood at $3.1 million, which was down 1916.49% from $3.6 million recorded in Q2 2025.
  • Puma Biotechnology's Non-cash Items' 5-year high stood at $4.0 million during Q1 2024, with a 5-year trough of $265000.0 in Q1 2022.
  • Over the past 5 years, Puma Biotechnology's median Non-cash Items value was $3.5 million (recorded in 2022), while the average stood at $2.7 million.
  • Per our database at Business Quant, Puma Biotechnology's Non-cash Items plummeted by 9114.6% in 2022 and then skyrocketed by 126211.21% in 2023.
  • Over the past 5 years, Puma Biotechnology's Non-cash Items (Quarter) stood at $3.8 million in 2021, then crashed by 72.53% to $1.0 million in 2022, then rose by 5.64% to $1.1 million in 2023, then soared by 227.72% to $3.6 million in 2024, then dropped by 13.08% to $3.1 million in 2025.
  • Its Non-cash Items was $3.1 million in Q3 2025, compared to $3.6 million in Q2 2025 and $355000.0 in Q1 2025.